These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

220 related items for PubMed ID: 12148901

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Juvenile mycosis fungoides treated with bexarotene and PUVA.
    Rodríguez-Vázquez M, García-Arpa M, González-García J.
    Int J Dermatol; 2007 Jan; 46(1):99-102. PubMed ID: 17214731
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Follicular mycosis fungoides: variability of a rare entity.
    Roeschm A, Schleyer V, Landthaler M, Vogt T.
    Skinmed; 2005 Jan; 4(1):12-7. PubMed ID: 15654159
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. A case of mycosis fungoides after CD30 positive anaplastic large cell lymphoma.
    Lee MW, Chi DH, Choi JH, Sung KJ, Moon KC, Koh JK.
    J Dermatol; 2000 Jul; 27(7):458-61. PubMed ID: 10935344
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Alitretinoin treatment in mycosis fungoides with CD30-positive large cell transformation.
    Park J, Kwon O, Park K, Chung H.
    Clin Exp Dermatol; 2017 Apr; 42(3):341-342. PubMed ID: 28211143
    [No Abstract] [Full Text] [Related]

  • 12. Coexistence of CD30-positive anaplastic large cell lymphoma and mycosis fungoides.
    Kang SK, Chang SE, Choi JH, Sung KJ, Moon KC, Koh JK.
    Clin Exp Dermatol; 2002 May; 27(3):212-5. PubMed ID: 12072011
    [Abstract] [Full Text] [Related]

  • 13. Bexarotene therapy for mycosis fungoides and Sézary syndrome.
    Abbott RA, Whittaker SJ, Morris SL, Russell-Jones R, Hung T, Bashir SJ, Scarisbrick JJ.
    Br J Dermatol; 2009 Jun; 160(6):1299-307. PubMed ID: 19222457
    [Abstract] [Full Text] [Related]

  • 14. Evaluation of new tumors in the setting of stage I/IIA mycosis fungoides.
    Harrington CR, Guillén DR, Pandya AG.
    Clin Lymphoma Myeloma; 2007 Jul; 7(7):480-5. PubMed ID: 17875239
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Bexarotene reverses alopecia in cutaneous T-cell lymphoma.
    Hanson M, Hill A, Duvic M.
    Br J Dermatol; 2003 Jul; 149(1):193-6. PubMed ID: 12890219
    [No Abstract] [Full Text] [Related]

  • 17. Polish Lymphoma Research Group Experience With Bexarotene in the Treatment of Cutaneous T-Cell Lymphoma.
    Sokolowska-Wojdylo M, Florek A, Zaucha JM, Chmielowska E, Giza A, Knopinska-Posluszny W, Kulikowski W, Prejzner W, Romejko-Jarosinska J, Paszkiewicz-Kozik E, Osowiecki M, Walewski J, Rogowski W, Grzanka A, Placek W, Lugowska-Umer H, Kowalczyk A, Nowicki R, Jurczak W.
    Am J Ther; 2016 Jul; 23(3):e749-56. PubMed ID: 24732904
    [Abstract] [Full Text] [Related]

  • 18. Treatment of refractory stage IV mycosis fungoides with bexarotene monotherapy.
    Otremba B.
    Dermatol Clin; 2008 Jan; 26 Suppl 1():51-2. PubMed ID: 18405188
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.